Less Than Half of Parents Surveyed Plan to Get COVID-19 Vaccine for Youngest Children
About 43% of parents surveyed said they would not get their young children vaccinated against COVID-19.
About 43% of parents surveyed said they would not get their young children vaccinated against COVID-19.
Vaccine effectiveness against breakthrough SARS-CoV-2 infections was 10.5% for patients with lymphoma.
Local and systemic reactions were reported less frequently after the fourth dose than after the third dose.
Increases in resistant infections from 2019 to 2020 were seen for carbapenem-resistant Acinetobacter and antifungal-resistant Candida auris.
The effectiveness of maternal vaccination against COVID-19 hospitalization in infants was 80% during delta and 38% during omicron.
A 50mcg booster dose of mRNA-1273.214 elicited significantly higher neutralizing antibody responses against omicron subvariants BA.4 and BA.5 in adults.
The Novavax COVID-19 vaccine is administered intramuscularly as a 2-dose primary series (0.5mL each), separated by 3 weeks.
Less than half of patients seroconverted after 2 doses of a COVID-19 vaccine, but 56% of those patients seroconverted after a third dose.
A subset of patients with non-small cell lung cancer have “very suboptimal” responses to COVID-19 vaccination, according to researchers.
Vaccination is estimated to have prevented 58% of expected deaths in adults from Sept. 1-30, 2021.